Feasibility study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2011
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Jul 2011 New trial record